In an exclusive and wide-ranging interview, Tom O'Leary, chief information officer (CIO) of leading contract research organisation (CRO), ICON, highlights how data is already revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes. O'Leary also touches on the incursion of tech companies into the medical research space, access issues, and the evolving requirements of sponsors.
The reason we are looking at data is that the therapies that are being developed are much more targeted and specific than ever before. For example, cancer is a collection of rare diseases, so finding patients that are going to see benefits from the therapies being developed is key
